(Q50918652)
Statements
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis (English)
Gillotin C
Bagnis C
Mamet JP
Peck RW
1 November 1997
scientific article published in November 1997